Your session is about to expire
← Back to Search
Diet Therapy for Type 2 Diabetes
Study Summary
This trial will compare the LoBAG diet to a control diet in 38 participants with DM2 over 12 weeks, measuring HgbA1c, weight, fasting plasma glucose, fasting serum insulin, postprandial plasma glucose and serum insulin, serum fructosamine, fasting serum lipids, stool samples for gut microbiome analysis, and quality of life surveys. Compliance outcomes will include urine nitrogen to creatinine ratio, survey data, three-day food diaries, and unannounced 24-hour diet recalls.
- Type 2 Diabetes
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many test subjects are being admitted to this experiment?
"That is correct. According to information seen on clinicaltrials.gov, registration for this medical study began June 19th 2017 and was last updated August 8th 2022. 50 patients are being sought at a single site."
Are there any available slots for individuals who are interested in participating in this trial?
"According to information posted on clinicaltrials.gov, this research endeavour is currently seeking out individuals for participation. The trial was initially released on June 19th 2017 and has since been updated as recently as August 8th 2022."
Share this study with friends
Copy Link
Messenger